Dimitrios Nasioudis, MD
Contact information
Hospital of the University of Pennsylvania
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
PCAM 3 West
Philadelphia, PA 19104
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
PCAM 3 West
Philadelphia, PA 19104
Education:
MD
Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece, 2013.
(Military Sciences)
Hellenic Military School of Combat Support Officer, Commissioned as 2nd lieutenant (OF-1) of the Hellenic Army Medical Corps, 2014.
Permanent linkMD
Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece, 2013.
(Military Sciences)
Hellenic Military School of Combat Support Officer, Commissioned as 2nd lieutenant (OF-1) of the Hellenic Army Medical Corps, 2014.
Selected Publications
Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA: Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. Int J Gynecol Cancer ijgc-2023- 004805, Dec 2023.Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F: Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. Int J Gynecol Cancer 33(12):1906-1912, Dec 2023.
Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, F Simpkins, Kim SH: “Utilization and outcomes of sentinel lymph node biopsy (SLNBX) for patients with cervical carcinoma; a multicenter database analysis” Focused ORAL Presentation. International Gynecologic Cancer Society Meeting, Seoul Nov 2023.
Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM: Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5, Nov 2023.
Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Martin L, Simpkins F, Giuntoli R 2nd: Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecol Oncol 177:14-19, Oct 2023.
Nasioudis D, Llaurado Fernandez M, Wong N, Powell D, Mills G, Westin S, Fader A, Carey M, Simpkins F: The spectrum of MAPKERK pathway genomic alterations in gynecologic malignancies: opportunities for novel therapeutic approaches. Gynecol Oncol 177:86-94, Oct 2023.
Nasioudis D, Labban N, Latif NA, Gysler S, Cory L, Kim SH, Giuntoli RL 2nd, EM Ko: Role of immunotherapy for lymph-node positive vulvar melanoma; utilization and outcomes. Int J Gynecol Cancer 33(9):1347-1353, Sep 2023.
Nasioudis D, George EM, Tanyi JL: Controversies in the Staging of Patients with Locally Advanced Cervical Cancer. Diagnostics (Basel) 13: 1747, May 2023.
D Nasioudis, S Gysler, NA Latif, EM Ko, L Cory, SH Kim, W Cliby, RL Giuntoli II: “ Higher rates of neo-adjuvant chemotherapy use among high-risk patients with advanced stage epithelial ovarian carcinoma is associated with improved outcomes” POSTER, 54th Annual Meeting of the Society of Gynecologic Oncology, Tampa Mar 2023.
D Nasioudis, S Gysler, EM Ko, L Cory, RL Giuntoli II, SH Kim, NA Latif: “Next generation sequencing reveals distinct molecular subgroups of endometrioid ovarian carcinoma” POSTER, 54th Annual Meeting of the Society of Gynecologic Oncology, Tampa Mar 2023.